{"id":"placebo-to-etoricoxib","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Gastrointestinal upset"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL416146","moleculeType":"Small molecule","molecularWeight":"358.85"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This selective inhibition of COX-2 results in reduced inflammation and pain, making it effective for treating conditions such as osteoarthritis and rheumatoid arthritis. Etoricoxib's mechanism of action is distinct from traditional NSAIDs, which inhibit both COX-1 and COX-2 enzymes.","oneSentence":"Etoricoxib is a nonsteroidal anti-inflammatory drug (NSAID) that selectively inhibits COX-2, reducing prostaglandin synthesis and inflammation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:28:35.751Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Osteoarthritis"},{"name":"Rheumatoid arthritis"}]},"trialDetails":[{"nctId":"NCT00092729","phase":"PHASE3","title":"An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-06-07","conditions":"Dysmenorrhea","enrollment":129},{"nctId":"NCT00269191","phase":"PHASE3","title":"A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-02-05","conditions":"Osteoarthritis","enrollment":528},{"nctId":"NCT00092768","phase":"PHASE3","title":"A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-03-01","conditions":"Osteoarthritis","enrollment":500},{"nctId":"NCT00092755","phase":"PHASE3","title":"An Investigational Drug in Patients With Osteoarthritis (0663-073)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-04-09","conditions":"Osteoarthritis","enrollment":548},{"nctId":"NCT00092781","phase":"PHASE3","title":"A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-03-01","conditions":"Osteoarthritis","enrollment":500},{"nctId":"NCT01980940","phase":"PHASE1, PHASE2","title":"The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-12-23","conditions":"Osteoarthritis Pain","enrollment":70},{"nctId":"NCT01208207","phase":"PHASE3","title":"A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-09-27","conditions":"Spondylitis, Ankylosing","enrollment":1015},{"nctId":"NCT01208181","phase":"PHASE3","title":"A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-09-27","conditions":"Arthritis, Rheumatoid","enrollment":1404},{"nctId":"NCT05683574","phase":"PHASE3","title":"Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in Brazil","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-05-30","conditions":"Third Molar Extraction","enrollment":""},{"nctId":"NCT05308420","phase":"PHASE4","title":"PENG Block vs Intrathecal Morphine in Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Kresimir Oremus, MD","startDate":"2022-04-03","conditions":"Total Hip Arthroplasty, Postoperative Pain","enrollment":60},{"nctId":"NCT00393354","phase":"PHASE3","title":"Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-04","conditions":"Recurrent Low Back Pain","enrollment":325},{"nctId":"NCT00242489","phase":"PHASE2","title":"Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1998-06","conditions":"Osteoarthritis","enrollment":1167},{"nctId":"NCT00393211","phase":"PHASE3","title":"Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-04","conditions":"Recurrent Low Back Pain","enrollment":319},{"nctId":"NCT01429168","phase":"PHASE4","title":"A Study of Etoricoxib in Participants With Osteoarthritis Not Responding to Analgesic Drugs (MK-0663-142)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2011-10","conditions":"Osteoarthritis","enrollment":""},{"nctId":"NCT00095017","phase":"PHASE2","title":"Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2004-11","conditions":"Bone Neoplasms","enrollment":""},{"nctId":"NCT01462370","phase":"PHASE3","title":"Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-11","conditions":"Dysmenorrhea","enrollment":139},{"nctId":"NCT00788710","phase":"PHASE3","title":"A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-10","conditions":"Acute Pain Following a Total Abdominal Hysterectomy","enrollment":430},{"nctId":"NCT00694369","phase":"PHASE3","title":"A Study to Asses the Effect of MK0663 in the Treatment of Patients With Postoperative Dental Pain (0663-092)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-06","conditions":"Postoperative Dental Pain","enrollment":588},{"nctId":"NCT00820027","phase":"PHASE3","title":"Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-12-15","conditions":"Pain, Postoperative","enrollment":776},{"nctId":"NCT00264147","phase":"PHASE2","title":"Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-01","conditions":"Rheumatoid Arthritis","enrollment":761},{"nctId":"NCT04462666","phase":"PHASE2","title":"Oral Huzhang Granules for Acute Gouty Arthritis","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2020-07-01","conditions":"Gouty Arthritis","enrollment":267},{"nctId":"NCT02954484","phase":"PHASE3","title":"Outcomes Of Perioperative Pregabalin On Total Knee Arthroplasty","status":"COMPLETED","sponsor":"National University Hospital, Singapore","startDate":"2015-04","conditions":"Pain, Postoperative","enrollment":116},{"nctId":"NCT01300780","phase":"NA","title":"Effect of an Anti-inflammatory on Tooth Sensitivity Caused by Bleaching","status":"COMPLETED","sponsor":"Eloisa Andrade de Paula","startDate":"2010-04","conditions":"Color Changes During Tooth Formation","enrollment":30},{"nctId":"NCT01246362","phase":"PHASE2","title":"Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Singapore General Hospital","startDate":"2011-07","conditions":"Knee Osteoarthritis","enrollment":65},{"nctId":"NCT02884986","phase":"NA","title":"Analgesia in Inguinal Hernia Repair Using a Cyclooxygenase-2-specific Inhibitor","status":"COMPLETED","sponsor":"Bnai Zion Medical Center","startDate":"2015-01","conditions":"Adverse Anesthesia Outcome","enrollment":60},{"nctId":"NCT01229774","phase":"PHASE3","title":"Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty","status":"COMPLETED","sponsor":"University of Regensburg","startDate":"2011-02","conditions":"Coxarthrosis, Arthroplasties Hip Replacement, Perioperative Blood Loss","enrollment":100},{"nctId":"NCT01259830","phase":"PHASE4","title":"Effectiveness of Etoricoxib as an Additive Analgesic to Epidural Analgesia in Colon or Rectal Fast-track Surgery","status":"TERMINATED","sponsor":"Claudia Spies","startDate":"2011-03","conditions":"Post-operative Pain","enrollment":81},{"nctId":"NCT01619150","phase":"PHASE2","title":"A Single Center 2-way Crossover Study to Investigate the Mechanism of Action of Etoricoxib in Subjects With Osteoarthritis Knee Pain","status":"COMPLETED","sponsor":"C4Pain","startDate":"2012-07","conditions":"Osteoarthritis","enrollment":39},{"nctId":"NCT00954785","phase":"PHASE4","title":"Etoricoxib in Acute Ankle Ligament Sprains","status":"WITHDRAWN","sponsor":"University of Cape Town","startDate":"2009-11","conditions":"Sprain","enrollment":""},{"nctId":"NCT00755521","phase":"PHASE4","title":"Study Assessing the Efficacy of Etoricoxib in Female Patients With Fibromyalgia","status":"UNKNOWN","sponsor":"Meir Medical Center","startDate":"2008-09","conditions":"Fibromyalgia","enrollment":80},{"nctId":"NCT00763685","phase":"PHASE4","title":"Study to Evaluate the Efficacy of Pre-operative Administration of Etoricoxib 120 mg, Etoricoxib 120 mg and Paracetamol 1 g Combination or Placebo in the Treatment of Postoperative Pain in Patients Undergoing Gynaecologic Laparoscopic Surgery","status":"TERMINATED","sponsor":"East Tallinn Central Hospital","startDate":"2010-06","conditions":"Pain","enrollment":40},{"nctId":"NCT01398930","phase":"NA","title":"Acupuncture as an Adjunctive Therapy to the Pharmacological Treatment in Patients With Chronic Pain in Osteoarthritis of the Knee: a Three Armed Randomized Placebo Controlled Trial","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2007-09","conditions":"Knee Osteoarthritis","enrollment":120},{"nctId":"NCT01304069","phase":"PHASE1","title":"Effect of Celecoxib and Etoricoxib on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol","status":"COMPLETED","sponsor":"Turku University Hospital","startDate":"2011-01","conditions":"Healthy","enrollment":12},{"nctId":"NCT01264237","phase":"PHASE4","title":"Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain","status":"UNKNOWN","sponsor":"Analgesic Solutions","startDate":"2011-03","conditions":"Postherpetic Neuralgia, Neuralgia","enrollment":120},{"nctId":"NCT01148303","phase":"PHASE4","title":"Trial of Etoricoxib (Arcoxia) Taken Prophylactically to Prevent Ramadan Headache","status":"COMPLETED","sponsor":"Hartford Hospital","startDate":"2010-07","conditions":"Headache, Fasting, Fasting Headache","enrollment":220},{"nctId":"NCT00554346","phase":"PHASE4","title":"A Randomized, Double Blind, Placebo-controlled Study to Assess the the Preemptive Benefit of Etoricoxib in Patients Receiving Anterior Cruciate Ligament Reconstruction","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2008-05","conditions":"Post-operational Pain","enrollment":64},{"nctId":"NCT00752921","phase":"PHASE4","title":"Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache","status":"UNKNOWN","sponsor":"Shaare Zedek Medical Center","startDate":"2008-09","conditions":"Headache","enrollment":200},{"nctId":"NCT00529594","phase":"NA","title":"Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2006-08","conditions":"Proliferative Diabetic Retinopathy","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo to etoricoxib","genericName":"Placebo to etoricoxib","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Etoricoxib is a nonsteroidal anti-inflammatory drug (NSAID) that selectively inhibits COX-2, reducing prostaglandin synthesis and inflammation. Used for Osteoarthritis, Rheumatoid arthritis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}